Discover 200 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 200
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Jackson MS, Baton Rouge LA, Metairie LA, New Orleans LA,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Jackson MS, Nashville TN, Atlanta GA, Houston TX,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Jackson MS, New Orleans LA, Mobile AL, Little Rock AR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Jackson MS, New Orleans LA, Little Rock AR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
for
Tibial Fractures, Pain
Location: Jackson MS, Nashville TN, Houston TX, Indianapolis IN,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 70+
Code: NCT07006675
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Jackson MS, New Orleans LA, Little Rock AR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
for
Chronic Kidney Disease,
Location: Jackson MS
Sponsor: University of Mississippi Medical Center
Sex: All
Age: 18 - 70+
Code: NCT07052539
Recruiting
Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Jackson MS, New Orleans LA, Memphis TN, Little Rock AR,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
for
Breast Reconstruction Surgery
Location: Jackson MS, Jacksonville FL, Wichita KS, Evanston IL,
Sponsor: W.L.Gore & Associates
Sex: Female
Age: 22+
Code: NCT06556654
Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Jackson MS, New Orleans LA, Memphis TN, Little Rock AR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase 2, Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: Jackson MS, Birmingham AL, Nashville TN, Atlanta GA,
Sponsor: Duke University
Sex: All
Age: 0 - 21
Code: NCT02418442
Recruiting
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for
Pulmonary Embolism
Location: Jackson MS, Shreveport LA, Jackson TN, Tyler TX,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT04798261
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Jackson MS, Columbus MS, Baton Rouge LA, Memphis TN,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Jackson MS, New Orleans LA, Nashville TN, Atlanta GA,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase 3, Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Jackson MS, Memphis TN, Birmingham AL, Pensacola FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Jackson MS, Alexandria LA, Mobile AL, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Jackson MS, New Orleans LA, Memphis TN, Little Rock AR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Jackson MS, New Orleans LA, Little Rock AR,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Jackson MS, New Orleans LA, Mobile AL, Little Rock AR,